InsiderTrades

Form 4 for ULBI ULTRALIFE CORP

Accepted 2023-11-01 00:00:00 ET · period of report 2023-10-30 · accession 0000933430-23-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2023-11-01 2023-10-30+ ULBI WHITMORE BRADFORD T Dir, 10% P - Purchase $7.14 +13.9K 1.19M +1% +$99.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-30 P A 10,171 $7.04 1,182,165 D — — (F1) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.9224 to $7.2491. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
2 Common Common Stock 2023-10-31 P A 2,600 $7.37 1,184,765 D — — (F2) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.22 to $7.489. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
3 Common Common Stock 2023-11-01 P A 1,100 $7.51 1,185,865 D — — (F3) The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.28 to $7.6199. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.